v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 17,327 $ 1,091
General and administrative 5,691 1,914
Total operating expenses 23,018 3,005
Loss from operations (23,018) (3,005)
Other income (expense):    
Foreign currency loss (50) (33)
Interest Income, Net 2,287 1,341
Total other income 2,237 1,308
Net loss $ (20,781) $ (1,697)
Net loss per share, basic $ (0.31) $ (0.06)
Net loss per share, diluted $ (0.31) $ (0.06)
Weighted-average number of shares used to compute net loss per share, basic 67,462,450 27,638,528
Weighted-average number of shares used to compute net loss per share, diluted 67,462,450 27,638,528
Comprehensive loss:    
Net Income (Loss) $ (20,781) $ (1,697)
Other comprehensive income (loss):    
Unrealized gain on investments, net of tax of $0 263 2
Comprehensive loss $ (20,518) $ (1,695)